Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

California Pizza Kitchen’s Big Comeback: Inside the Deal Powering Its Next Chapter

California Pizza Kitchen enters a new era as fresh investment fuels growth, innovation, and global expansion—showing how legacy restaurant brands stay relevant.

These Are the Tech Gifts Everyone Is Fighting Over This Holiday Season

Holiday shopping heats up as Tom’s Guide editor Kate Kozuch reveals the tech gifts everyone wants, from wellness gadgets to gaming buzz—and how to score deals!

Big Business This Week: Xmas tricks retailers use to “hack our minds”

How do brands keep consumers spending even when they're strapped for cash at Xmas?

The case for making failing movies

Some movies do badly at the box office, but that doesn't mean we shouldn't make them.

The Hidden Skill Every Great Philanthropist Needs

PIMCO’s John Studzinski on markets, leadership, and why long-term thinking matters as much in giving as it does in investing.

Buy Now or Wait? A Real Estate CEO Breaks Down the Market

High rates and low inventory continue to squeeze buyers. Century 21 CEO Mike Miedler breaks down what’s next for U.S. housing.

Load More